
Category: Robert F. Kennedy Jr.
Affordability Conservative Review DC Exclusives - Blurb Food dyes Newsletter: Culture Wars Robert F. Kennedy Jr.
Billion-Dollar Snack Companies Suddenly Care About Affordability After Jacking Up Prices for Years
‘Could undermine his goal to lower costs for Americans’
Trump Admin Moves to Defund Hospitals Performing Trans Procedures on Children
The Trump administration on Thursday moved to cut off all federal funding from hospitals that perform transgender medical procedures on minors, escalating its crackdown on what officials describe as irreversible and unproven interventions on children.
The post Trump Admin Moves to Defund Hospitals Performing Trans Procedures on Children appeared first on .
Blaze Media Department of health and human services Donald Trump Rfk Robert F. Kennedy Jr. Trump administration
RFK Jr. moves to ban transgender procedures for children: ‘This is not medicine; it is malpractice’

Secretary of Health and Human Services Robert F. Kennedy Jr. is leading the charge to protect children across America from life-shattering transgender procedures.
Kennedy announced a new declaration on Thursday moving to ban sex-altering operations, hormone replacement therapy, and other irreversible medical procedures that target children suffering from gender dysphoria. Rather than affirming tragic delusions and relying on taxpayers to subsidize these experimental interventions, Kennedy’s health department is working to pull funding and impose enforcement actions on the medical institutions that profit off of vulnerable children.
‘We’re done with junk science driven by ideological pursuits.’
“The Trump administration will not stand by while ideology, misinformation, and propaganda push vulnerable young people into decisions they cannot fully understand and that they can never reverse,” Kennedy said Thursday.
“There is divine worth in every person, and it shines most brightly in our children. That worth commands us to protect them.”
RELATED: ‘This is a must-win’: These 4 Republicans voted against banning trans surgeries on children
Photo by Drew Angerer/Getty Images
Kennedy was flanked by numerous health officials in President Donald Trump’s administration, Republican lawmakers, and even Chloe Cole, a de-transitioner who described her own traumatic experience with the medical industry.
“It’s not too late to accept the beautiful way God has created you,” Cole said during her remarks.
Kennedy went on to describe the predatory nature of the medical institutions that convince American youth that sex is malleable and that a life-altering, irreversible medical procedure is a one-size-fits-all solution to the mental health struggles for these children.
RELATED: ‘Send in the next guy’: Nicki Minaj savages Newsom over his desire to ‘see trans kids’
Photo by Andrew Harnik/Getty Images
“They betray the estimated 300,000 American youth ages 13 to 17 conditioned to believe that sex can be changed,” Kennedy said. “They betrayed their Hippocratic Oath to ‘do no harm.’ So-called gender affirming care has inflicted lasting physical and psychological damage on vulnerable young people. This is not medicine; it is malpractice.”
“We’re done with junk science driven by ideological pursuits, not the well-being of children.”
Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!
Killing drug ads won’t lower prices — it will kill innovation

The United States is one of the few countries that allows prescription drugmakers to speak directly to patients. That simple fact now fuels political calls to “ban the ads.” But restricting direct-to-consumer advertising would do more than change what runs during football games. It would shrink the flow of information to patients and push our system toward the bureaucratic throttling that has turned other countries into innovation laggards.
Advertising is part of a dynamic market process. Entrepreneurs inform consumers about new products, and when profits are high, firms have every incentive to improve quality and expand access.
The pattern is clear: The more Washington intervenes, the fewer cures Americans get.
New, cheaper treatments need to be brought to consumers’ attention. Otherwise, people stay stuck with older, more expensive options, and competition falters. Banning pharmaceutical advertising would hobble innovative firms whose products are not yet known and leave those seeking medical care less informed.
Critics warn that “a growing proliferation of ads” drives demand for costly treatments, even when less expensive alternatives exist. Yet a recent study in the Journal of Public Economics finds that exposure to pharmaceutical ads increases drug utilization across the board — including cheaper generics and non-advertised medications. In short, advertising pushes people who need care to make better, more informed decisions.
A market-based system rewards risk-taking and innovation. Despite the many flaws in American health care, the United States leads the world in medical breakthroughs — from cancer immunotherapies to vaccines developed in record time. That success wasn’t created by government decree. It came from competition: firms communicating openly about their products, fighting for patients, and reinvesting earnings into the next generation of lifesaving discoveries.
Sure, some regulations are adopted with good intentions. But drug ads are already heavily regulated, and a full ban would create serious unintended consequences — including the unseen cost of innovative drugs that will never reach patients because firms won’t invest in developing treatments they are barred from promoting.
American health care is now regulated to the point of satisfying no one. Patients face rising costs. Physicians navigate a Kafkaesque maze of top-down rules. Taxpayers foot the bill for decisions made by distant bureaucracies. Measures associated with socialized medicine continue creeping into the marketplace.
Price controls in the Inflation Reduction Act are already cutting into pharmaceutical research and development. One study estimates roughly 188 fewer small-molecule treatments in the 20 years after its enactment. The pattern is clear: The more Washington intervenes, the fewer cures Americans get.
RELATED: Trump faces drugmakers that treat sick Americans like ATMs
Photo by Andrew Harnik/Getty Images
The answer to the problems in American health care isn’t more government. It’s less. Expected profitability drives investment in biomedical research. Imposing new advertising bans or European-style price controls would mean lower-quality care, higher mortality, and the erosion of America’s leadership in medical innovation.
The United Kingdom offers a warning. Once a global leader, it drove investment offshore through overregulation and rigid price controls. Today, only 37% of new medicines are made fully available for their licensed uses in Britain. Americans spend more, but they also live longer: U.S. cancer patients outlive their European counterparts for a reason.
Discovering new drugs is hard. Every breakthrough begins with the freedom to imagine, to compete, and to communicate. Strip companies of the ability to inform patients, and you strip away the incentive to develop the next cure. Competitive markets — not centralized control — will fuel tomorrow’s medical miracles.
RFK’s alleged sexting partner splits with another publication amid scandal-ridden book release

Olivia Nuzzi’s fall from grace continues as she parts ways with another magazine.
Once a rising star in the journalism world, Nuzzi was first fired from the New Yorker in 2024 after news broke of her alleged sexting with then-presidential candidate Robert F. Kennedy Jr., breaking the most basic forms of journalistic ethics and collapsing her engagement to then-Politico reporter Ryan Lizza. Nuzzi was later picked up by Vanity Fair to be West Coast editor.
The overlapping narratives inevitably caused a media firestorm.
Nearly a year later, the scandal has resurfaced after Nuzzi announced the release of her book “American Canto,” which apparently details her alleged behavior with Kennedy but refers to him only as “the politician.”
In the aftermath of the renewed interest in and attention to the scandal, Nuzzi and Vanity Fair “have agreed to part ways,” according to the Wall Street Journal.
RELATED: Trump calls New York Magazine’s Olivia Nuzzi an ‘unattractive wack job’
Photo by Paul Morigi/Getty Images for HBO
Nuzzi’s attempt at a comeback tour was met with a series of bombshell exposés written by her former fiancé, who began his career as an independent journalist following the scandal.
Lizza detailed in his Substack series how he found out about Nuzzi’s alleged sexting not just with Kennedy in 2024, but also with former presidential candidate Mark Sanford in 2020. Lizza went on to detail a toxic dynamic between Nuzzi and Kennedy, including graphic details about their sexual proclivities and the intense betrayal, while she insisted that the relationship was merely a “digital” one.
Despite the overwhelming evidence and multiple accounts of the behavior, Kennedy has denied the allegations.
RELATED: What the mainstream media’s outrage over RFK Jr.’s ‘affair’ is REALLY about
Photo by Kevin Dietsch/Getty Images
The overlapping narratives inevitably caused a media firestorm, but it may not have translated into monetary success for Nuzzi’s new book.
Since its release on December 2, “American Canto” sat at No. 5,546 on Amazon’s best-seller list and at No. 3,059 in the Kindle store. Despite the onslaught of media attention, the supposedly “mesmerizing firsthand account of the warping of American reality over the past decade” is currently sitting at a brutal 1.69-star rating on Goodreads.
Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!
Make America Healthy Again: Restoring the Republic’s Vitality
Health Secretary Robert F. Kennedy Jr. and President Donald Trump may not have been obvious allies — one hailing from…
Part 2: How I Found Out My Journalist Side Piece Was Cheating on Me With Her Fiancé Again
![]()
She did it again. It was roughly 107 days later. Another triumph over evil and incompetence. Another lump of salt in time’s gaping wound. Joseph R. Biden, the nominal president, had flamed out like a California wildfire kissing the Pacific Ocean for the first time. Mouths forced open, cheeks clenched tight. Engorged tongues tangling like cattails in the briny muck of beachfront bliss. The low whine of steam clouds billowing breast-like over the horizon. Almighty nature tamed at last.
The post Part 2: How I Found Out My Journalist Side Piece Was Cheating on Me With Her Fiancé Again appeared first on .
How I Found Out My Journalist Side Piece Was Cheating on Me With Her Fiancé
The humidity unfurled in torrid pulse-strokes drenched with soft-skinned summer musk, swooning like a locust swarm up and down Fifth Avenue. Chaos lingered in the waning wreckage of a strawberry moon. Shadows whispered under Saturn’s winking eye. American flags flailed recklessly as darkness hunkered down. I wallowed in the pale dusk, still reeling from a nuclear aftershock of psychosexual delusion. Red and white, seared together pink as flesh. The stars were out. I sang the blues.
The post How I Found Out My Journalist Side Piece Was Cheating on Me With Her Fiancé appeared first on .
search
categories
Archives
navigation
Recent posts
- Ted’s Excellent Adventures January 11, 2026
- A Righteous Man in Japan January 11, 2026
- Rushdie on Death and Dying (While Remaining Alive and Well) January 11, 2026
- When You (Try) To Ignore God January 11, 2026
- The ticking clock no conservative wants to admit about 2026 midterms January 11, 2026
- Chuck Colson: Nixon loyalist who found hope in true obedience January 11, 2026
- Marco Masa, Anton Vinzon, Rave Victoria, Eliza Borromeo advance to next round of Big Wildcard January 11, 2026







